Xevudy 500 mg concentrate for solution for infusion
- Licence status
- Withdrawn: 18/02/2026
- Active substances
- Sotrovimab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/21/1562/001
- Licence holder
- GlaxoSmithKline Trading Services Limited
Product documents
Licence information
- ATC code
- J06BD05 sotrovimab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/12/2021